Diagnostic efficacy of serum anti-phospholipase A2 receptor antibodies for idiopathic membranous nephropathy in patients with diabetic kidney disease

Q Wang, Z Dong, W Zhang, X Liu, Y Qu, S Duan… - Clinica Chimica …, 2020 - Elsevier
Aim Serum anti-phospholipase A2 receptor (anti-PLA2R) antibodies are highly accurate in
diagnosing idiopathic membranous nephropathy (IMN) in populations with kidney disease …

Diagnostic efficacy of serum anti-phospholipase A2 receptor antibodies for idiopathic membranous nephropathy in patients with diabetic kidney disease.

Q Wang, ZY Dong, WG Zhang, XM Liu… - Clinica Chimica Acta; …, 2019 - europepmc.org
Aim Serum anti-phospholipase A2 receptor (anti-PLA2R) antibodies are highly accurate in
diagnosing idiopathic membranous nephropathy (IMN) in populations with kidney disease …

Diagnostic efficacy of serum anti-phospholipase A2 receptor antibodies for idiopathic membranous nephropathy in patients with diabetic kidney disease

Q Wang, ZY Dong, WG Zhang… - … journal of clinical …, 2020 - pubmed.ncbi.nlm.nih.gov
Aim Serum anti-phospholipase A2 receptor (anti-PLA2R) antibodies are highly accurate in
diagnosing idiopathic membranous nephropathy (IMN) in populations with kidney disease …

Diagnostic efficacy of serum anti-phospholipase A2 receptor antibodies for idiopathic membranous nephropathy in patients with diabetic kidney disease

Q Wang, ZY Dong, WG Zhang, XM Liu, YL Qu… - Clinica Chimica …, 2019 - hero.epa.gov
AIM: Serum anti-phospholipase A2 receptor (anti-PLA2R) antibodies are highly accurate in
diagnosing idiopathic membranous nephropathy (IMN) in populations with kidney disease …